Sep 20, 2021
By Jane Brown
Word from Pfizer Monday, its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
The vaccine made by Pfizer and its German partner BioNTech is already available for anyone 12 and older in the United States, Canada, and around the world.
For elementary school-aged kids, Pfizer researchers tested a much lower dose; a third of the amount that’s in each shot given now.
Yet Pfizer’s senior vice president told The Associated Press that after their second dose, children 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults.
Dr. Peter Yuni is scientific director of the COVID-19 Science Advisory Table. He told Zoomer Radio’s Fight Back with Libby Znaimer, he expects a COVID vaccine for younger children will be approved by Health Canada in November.